The above results indicated that B/BM in lung cancer patients was associated with positive EGFR mutations in cfDNA and that the higher abundance of sensitive EGFR mutations in cfDNA might be a risk factor for developing brain metastases. This evidence concerns the gene EGFR and lung cancer.